Paris, France (March 14, 2006) - Aureus Pharma a leading provider of knowledge management solutions to aid discovery in the life sciences industry, today announces the release of a new product AurWEBTM. AurWEB is a web portal enabling access to all of Aureus Pharma’s knowledge databases and analysis applications. Using AurWEB to access AurSCOPE® knowledge databases, researchers can benefit from high quality quantitative chemical and biological data to accelerate drug discovery.

AurWEB is available on a subscription basis, thus offering customers flexible usage of Aureus’ comprehensive knowledge databases which include AurSCOPE® GPCR, Ion Channel, Kinase, ADME/Drug-Drug Interactions and hERG. AurWEB subscribers connect to the Aureus Pharma portal in a highly secure mode. Deployment of AurWEB requires only classical computing and networking infrastructure.

“We are proud to introduce AurWEB to the market” said Dr. André Michel, CEO of Aureus Pharma. “AurWEB will allow us to bring the power of Aureus Pharma solutions to a wider community of life science researchers.”

About Aureus Pharma

Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharmaceutical topics including ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit www.aureus-pharma.com

Contact:
Mary E. Donlan, Ph.D
Director of Marketing & Sales
+33 6 76 19 51 77
mary.donlan@aureus-pharma.com